V-Wave
Erez Rozenfeld is a seasoned executive with extensive experience in the healthcare and medical technology sectors. Since October 2013, Erez has served as President of V-Wave, focusing on strategic development aimed at enhancing the lives of individuals with heart failure and cardiovascular diseases, overseeing key operations from R&D to commercialization in Europe. Previously, Erez held the position of CEO at both V-Wave and RapiDx, where innovative self-testing solutions for home use were developed. Co-founding Aesthera Corporation, Erez played a crucial role in international operations, advancing light-based treatments in the medical aesthetic field. Leadership roles at Lumenis UK as Managing Director, Teva Medical as Key Account Director, and Pharma Klal as Sales Director further underscore Erez's enduring impact on business growth and market expansion in the healthcare industry. Erez holds an Executive MBA in Marketing & Finance and a BA in Economy and Business Administration, both from Bar-Ilan University.
This person is not in the org chart
V-Wave
V-Wave Ltd. is a privately held company with offices in Israel and the US. The company is focused on developing percutaneous implantable devices for treating patients with Chronic Heart Failure (HF). V-Wave’s vision is to help patients who remain with disabling symptoms or need hospitalization despite optimized medical treatment. V-Wave hasdeveloped a proprietary interatrial shunt intended to relieve symptoms, reduce hospitalization, increase exercise capacity and improve the overall quality of life.The original concept and development started in Israel with a talented team of engineers and medical scientists. The company’s senior management has decades of experience successfully developing, clinically testing and bringing to market multiple implantable cardiovascular devices.